慢阻肺患者急诊管理与出院时指南治疗依从性
结果显示出院时53.8%患者获三联治疗处方，既往使用三联治疗、长期家庭氧疗和流感疫苗接种与处方独立相关。
要点
- 急诊出院的慢阻肺急性加重患者中约三分之一未接受指南推荐的吸入三联治疗。
- 既往已用三联治疗、长期家庭氧疗和流感疫苗接种者更可能在出院时获三联治疗处方。
- 出院6个月内36.0%患者因慢阻肺急性加重需住院，提示急诊管理优化空间。
核心结论
- 急诊出院的慢阻肺患者中约三分之一未接受指南推荐的吸入三联治疗，需干预以规范急诊管理并提高指南依从性。
主要发现
- 227例患者平均年龄74.4岁，70.9%为男性；93.4%既往有慢阻肺诊断，41.0%已在用维持性吸入三联治疗。
- 出院时53.8%的患者被处方吸入三联治疗。
- 与三联治疗处方独立相关的因素包括既往使用吸入三联治疗（OR 9.4）、长期家庭氧疗（OR 4.3）和流感疫苗接种（OR 3.1）。
- 出院6个月后36.0%的患者因慢阻肺急性加重需住院。
关键数值与推荐
- 出院时吸入三联治疗处方率为53.8%（227例慢阻肺急性加重急诊出院患者）。
- 既往吸入三联治疗OR 9.4、长期家庭氧疗OR 4.3、流感疫苗接种OR 3.1，均为出院三联治疗处方的独立相关因素。
- 出院6个月内因慢阻肺急性加重住院比例为36.0%。
临床怎么用
- 呼吸科智能体应提示：急诊慢阻肺急性加重患者出院前需评估是否符指南推荐的吸入三联治疗指征，尤其关注既往未用三联治疗、未行长期家庭氧疗或未接种流感疫苗者。
- 对出院时未获三联治疗处方的患者，应提示临床团队复核指南依从性并考虑优化维持治疗。
局限性
- 单中心回顾性观察性研究，样本来自西班牙一家医院2022年下半年，结果外推需谨慎。
- 原文摘要未报告其他局限性信息。
以上解读依据论文摘要（全文未开放获取或许可不允许翻译转载）。
原文
Heart Lung. 2026 Sep-Oct;79:102795. doi: 10.1016/j.hrtlng.2026.102795. Epub 2026 Apr 14. ABSTRACT BACKGROUND: Chronic obstructive pulmonary disease (COPD) exacerbations are a frequent cause of emergency department visits and are associated with high morbidity, mortality, and healthcare costs. These visits represent an opportunity to optimize patient management and align treatment with guideline recommendations, particularly regarding inhaled triple therapy. OBJECTIVES: To describe the clinical characteristics and management of COPD patients in the emergency department and to identify factors associated with inhaled triple therapy prescription at discharge. METHODS: Retrospective observational study including patients aged >18 years attended at the emergency department of the Hospital Clínico Universitario (Zaragoza, Spain) between July and December 2022, with a diagnosis of COPD exacerbation at discharge. Demographic, clinical, laboratory, and therapeutic variables were analyzed. Logistic regression identified independent predictors of inhaled triple therapy prescription at discharge. RESULTS: A total of 227 patients were included (mean age: 74.4 years; 70.9% male). Most (93.4%) had a prior COPD diagnosis, and 41.0% were already on maintenance inhaled triple therapy. At discharge, inhaled triple therapy was prescribed in 53.8% of the cases. Independent variables associated with triple therapy prescription included prior use of inhaled triple therapy (odds ratio [OR]:9.4), long-term home oxygen therapy (OR:4.3), and influenza vaccination (OR:3.1). Six months after discharge, 36.0% of patients required hospital admission for COPD exacerbation. CONCLUSIONS: One-third of COPD patients discharged from the emergency department do not receive guideline-recommended inhaled triple therapy. Interventions aimed at standardizing and optimizing emergency department management are needed to improve adherence to clinical guidelines and improve patient outcomes. PMID: 41985297 | DOI: 10.1016/j.hrtlng.2026.102795
引用
- 指南共识 · 慢阻肺：Management of patients with COPD in the emergency department and treatment compliance with clinical guideline recommendations at discharge
供执业医师工作参考，不替代临床判断；数值与分级以指南原文为准。